Patient Assessment of Topical Anesthetic Effectiveness for Intravitreal Injections

NCT01027611 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Pain

Interventions

DRUG: proparacaine HCL 0.5%
DRUG: proparacaine HCL 0.5% + 4% lidocaine solution
DRUG: 3.5% viscous lidocaine gel

Sponsor

Illinois Retina Associates